Diagnosoft, a developer of MRI image analysis software that assists in the diagnosis, staging and monitoring of cardiovascular disease, has raised $4 million in a series B financing round, led by Technology Development Fund of Cairo, Egypt.
The Morrisville, N.C.-based company said it intends to use the new capital to support market expansion of Diagnosoft Harp, Diagnosoft Plus and Diagnosoft Senc. The infusion of funds will also serve to further the development of other MR image analysis technologies.
In other company news, Diagnosoft’s board of directors has appointed Firas BenAchour president and CEO of Diagnosoft and a member of the board. With 20 years of healthcare IT experience, BenAchour will work with the executive team.
He started his career in business development, sales and marketing, and moved into executive management, according to Diagnosoft. His career spans various healthcare companies, including HBOC and Per-Se Technologies (both acquired by McKesson), CareFusion (acquired by Cardinal Health) and CareSystems.
"There are many techniques for analyzing the left ventricle of the heart—echo, nuclear medicine, CT…but we are focused on the emerging technology of MRI for the cardiac market. We are kind of a one-stop shop for analysis of the four MRI techniques—CINE, perfusion, delayed enhancement or viability and function or strain,” said Jerry Prince, MD, Diagnosoft co-founder.